COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,785 Articles (22,523 medRxiv, 8,262 bioRxiv)

Most recent first Previous |  Page 1794: Articles 17931-17940  | Next

Radius of Gyration as predictor of COVID-19 deaths trend with three-weeks offset
Hernando de Castro, A., Mateo, D., Bayer, J., Barrios, I.
10.1101/2021.01.30.21250708 — Posted: 2021-02-02
Neutralization of SARS-CoV-2 VOC 501Y.V2 by human antisera elicited by both inactivated BBIBP-CorV and recombinant dimeric RBD ZF2001 vaccines
Huang, B., Dai, L., Wang, H., Hu, Z., Tan, W., Gao, G. F., Yang, X.
10.1101/2021.02.01.429069 — Posted: 2021-02-02 Discussion: Onsite
Production of SARS-CoV-2 virus-like particles in insect cells
mi, Y., Xie, T., Zhu, B., tan, J., Li, X., Luo, Y., Li, F., Niu, H., Han, J., Lv, W., Wang, J.
10.1101/2021.01.30.428979 — Posted: 2021-02-01
Host PDZ-containing proteins targeted by SARS-Cov-2
Caillet-Saguy, C., Durbesson, F., REZELJ, V. V., Gogl, G., Tran, Q. D., Twizere, J.-C., Vignuzzi, M., Vincentelli, R., Wolff, N.
10.1101/2021.02.01.429176 — Posted: 2021-02-01
In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays
Tucker, S. P., Goodall, S., Molloy, P., Julander, J., Mendenhall, M., Friedland, P.
10.1101/2021.01.31.426979 — Posted: 2021-02-01
Enhanced immunogenicity of a synthetic DNA vaccine expressing consensus SARS-CoV-2 Spike protein using needle-free immunization
Alamri, S. S., Alluhaybi, K. A., Alhabbab, R. Y., Algaissi, A., Almahboub, S., Alfaleh, M. A., Abujamel, T. S., Abdulaal, W., ElAssouli, M.-Z., Alharbi, R., Hassanain, M., Hashem, A. M.
10.1101/2021.02.01.429219 — Posted: 2021-02-01 Discussion: Onsite
Nanotraps for the containment and clearance of SARS-CoV-2
Chen, M., Rosenberg, J., Cai, X., Lee, A. C. H., Shi, J., Nguyen, M., Wignakumar, T., Mirle, V., Edobor, A. J., Fung, J., Donington, J. S., Shanmugarajah, K., Chang, E. B., Randall, G., Penaloza-MacMaster, P., Tian, B., Madariaga, M. L., Huang, J.
10.1101/2021.02.01.428871 — Posted: 2021-02-01
Identification of a conserved neutralizing epitope present on spike proteins from highly pathogenic coronaviruses
Huang, Y., Nguyen, A. W., Hsieh, C.-L., Silva, R., Olaluwoye, O. S., Wilen, R., Kaoud, T. S., Azouz, L. R., Qerqez, A. N., Le, K. C., Bohanon, a. L., DiVenere, A. M., Liu, Y., Amengor, D., Dalby, K., D'Arcy, S., McLellan, J. S., Maynard, J. A.
10.1101/2021.01.31.428824 — Posted: 2021-02-01
Environmentally-induced mdig is a major contributor to the severity of COVID-19 through fostering expression of SARS-CoV-2 receptor NRPs and glycan metabolism
Chen, F.
10.1101/2021.01.31.429010 — Posted: 2021-02-01
Nelfinavir markedly improves lung pathology in SARS-CoV-2-infected Syrian hamsters despite a lack of an antiviral effect
Foo, C. S., Abdelnabi, R., Kaptein, S. J. F., Zhang, X., ter Horst, S., Mols, R., Delang, L., Rocha-Pereira, J., Coelmont, L., Leyssen, P., Dallmeier, K., Vergote, V., Heylen, E., Vangeel, L., Chatterjee, A. K., Annaert, P., Augustijns, P., De Jonghe, S., Jochmans, D., Weynand, B., Neyts, J.
10.1101/2021.02.01.429108 — Posted: 2021-02-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).